Amgen (AMGN) Total Liabilities (2009 - 2026)

Amgen has reported Total Liabilities for 18 years, with the latest figure at $83.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities changed 0.19% year-over-year to $83.3 billion; the trailing twelve-month figure through Mar 2026 stood at $83.3 billion (changed 0.19% YoY), and the FY2025 full-year result was $81.9 billion, down 4.69% from the prior year.
• Total Liabilities for Q1 2026 stood at $83.3 billion, up from $81.9 billion in the prior quarter.
• The five-year high for Total Liabilities was $90.9 billion in Q4 2023, with the low at $56.9 billion in Q2 2022.
• Average Total Liabilities over 5 years is $78.2 billion, with a median of $83.2 billion recorded in 2025.
• Year-over-year, Total Liabilities surged 47.94% in 2023 and decreased 5.46% in 2024.
• Tracing AMGN's Total Liabilities over 5 years: stood at $61.5 billion in 2022, then surged by 47.94% to $90.9 billion in 2023, then slipped by 5.46% to $86.0 billion in 2024, then dropped by 4.69% to $81.9 billion in 2025, then rose by 1.69% to $83.3 billion in 2026.
• The last three Total Liabilities figures came in at $83.3 billion (Q1 2026), $81.9 billion (Q4 2025), and $80.5 billion (Q3 2025), per Business Quant data.

Peer Comparison